Morgan Stanley Initiates Integra Lifesciences(IART.US) With Sell Rating, Announces Target Price $20
Integra LifeSciences Assumed With an Underweight at Morgan Stanley
Reasons to Retain IART Stock in Your Portfolio for Now
IART Stock to Gain From New Study Findings on DuraSeal Dural Sealant
Integra's DuraSeal Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research
J.P. Morgan Maintains Integra Lifesciences(IART.US) With Sell Rating, Cuts Target Price to $24
Money Mover OP : $Medtronic (MDT.US)$ $Intuitive Surgical (ISRG.US)$